Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area pi3k akt signaling pdk 1'

Search results for: 'research area pi3k akt signaling pdk 1'

Items 1-10 of 54

Page
per page
  1. PP 1
    A8215 PP 1
    Target: Src|EGFR|JAK|ZAP-70
    Summary: Src family tyrosine kinase inhibitor
  2. DMH-1
    B3686 DMH-1
    Target: BMP and Other Activin Receptors
    Summary: Selective BMP ALK2 receptor
      insoluble in H2O; insoluble in EtOH; ≥9.51 mg/mL
  3. LRRK2-IN-1
    A3558 LRRK2-IN-1
     1 Citation
    Target: LRRK2|DCLK2
    Summary: LRRK2 inhibitor,cell-permeable and ATP competitive
      ≥28.55 mg/mL
  4. Sorafenib Tosylate
    A8245 Sorafenib Tosylate
     1 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥31.85 mg/mL
  5. SB525334
    A5602 SB525334
    Summary: (TGF-beta1) receptor inhibitor
      ≥34.3 mg/mL
  6. LDN-193189
    A8324 LDN-193189
    Target: BMP and Other Activin Receptors
    Summary: ALK inhibitor,potent and selective
      insoluble in DMSO; insoluble in EtOH; insoluble in H2O
  7. Sorafenib
    A3009 Sorafenib
     2 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥23.25 mg/mL
  8. RAF265
    A8313 RAF265
    Target: Raf|VEGFR
    Summary: Multiple intracellular kinases inhibitor
      ≥25.9 mg/mL
  9. Motesanib
    A3632 Motesanib
    Target: VEGFR
    Summary: Inhibitor of Flk-1/Flt-4/PDGFR-/c-Kit
      ≥42 mg/mL
  10. R406
    A8546 R406
     1 Citation
    Target: Syk
    Summary: SYK inhibitor,potent and ATP-competitive
      ≥31.45 mg/mL

Items 1-10 of 54

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 2item
  2. Axl 2item
  3. ALK 4item
  4. c-FMS 1 item
  5. c-Kit 2item
  6. c-MET 2item
  7. c-RET 2item
  8. CSF-1R 1 item
  9. EGFR 3item
  10. FGFR 3item
  11. FLT3 5item
  12. HER2 2item
  13. IGF1R 2item
  14. IRAK 1 item
  15. ITK 1 item
  16. LRRK2 2item
  17. PDGFR 7item
  18. Spleen Tyrosine Kinase (Syk) 3item
  19. Src 3item
  20. Tie-2 2item
  21. Trk 1 item
  22. VEGFR 20item
Specificity
  1. Selective 43item
Reversibility
  1. Reversible 2item
  2. Irreversible 1 item
Target
  1. Raf 4item
  2. Aurora Kinases 1 item
  3. CSF-1R 1 item
  4. FLT3 6item
  5. VEGFR 23item
  6. PDGFR 12item
  7. c-Kit 6item
  8. RET 2item
  9. IRAK 1 item
  10. Bcr-Abl 4item
  11. FGFR 4item
  12. Insulin-like growth factor receptors(IGFRs) 1 item
  13. MET 1 item
  14. Src 5item
  15. Trk Receptors 2item
  16. EGFR 4item
  17. BMP and Other Activin Receptors 2item
  18. JAK 1 item
  19. Syk 3item
  20. c-MET 3item
  21. LRRK2 2item
  22. Insulin and Insulin-like Receptors 1 item
  23. ALK 1 item
  24. Tie-2 2item
  25. Ron 1 item
  26. Insulin Receptors 1 item
  27. IRG-1R 1 item
  28. ZAP-70 1 item
  29. Fyn kinase 1 item
  30. c-Fms tyrosine kinase 1 item
  31. Mer tyrosine kinase 1 item
  32. ITK 1 item
  33. DCLK2 1 item
Related Disease
  1. Acute Myeloid Leukemia 1 item
  2. Adrenocortical Carcinoma 1 item
  3. Advanced Renal Cell Carcinoma 1 item
  4. Autoimmune Diseases 1 item
  5. Bladder Cancer 3item
  6. Breast Cancer 10item
  7. Cancer 36item
  8. Cervical Cancer 1 item
  9. Clear Cell Renal Cell Carcinoma 1 item
  10. Colon Cancer 1 item
  11. Colon Carcinoma 3item
  12. Colorectal Cancer 9item
  13. Glioblastoma 4item
  14. Glioma 1 item
  15. Leukemia 2item
  16. Liver Cancer 1 item
  17. Lung Cancer 4item
  18. Lung Carcinoma 2item
  19. Lymphoma 2item
  20. Melanoma 1 item
  21. Multiple Myeloma 2item
  22. Myeloma 1 item
  23. Non-small Cell Lung Cancer 5item
  24. Ovarian Cancer 3item
  25. Pancreatic Cancer 3item
  26. Prostate Cancer 4item
  27. Pulmonary Arterial Hypertension 1 item
  28. Renal Cancer 2item
  29. Renal Cell Carcinoma 2item
  30. Thyroid Cancer 3item